Burke Steven Keith
SEC CIK 1619834 · EDGAR
BoughtSold
Most active insiders at SCYX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Macleod ivor | CFO | — | — |
| 2 | Tinmouth Brian Philippe | Dir | — | — |
| 3 | Sukenick Scott | CLO | — | — |
| 4 | Angulo Gonzalez David | CEO, Dir | — | — |
| 5 | Burke Steven Keith | Dir | — | — |
| 6 | Macdonald Guy | Dir | — | — |
| 7 | HANHAM ANN | Dir | — | — |
| 8 | HASTINGS DAVID C | Dir | — | — |
| 9 | ANIDO ARMANDO | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-22 16:02 | 2026-09-18 | SCYX | SCYNEXIS INC | Burke Steven Keith | Dir | A - Grant | $0.00 | +5,750 | 5,750 | New | $0 |
| MT | 2026-02-04 | 2026-02-02 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.39 | -67.7K | 948.4K | -7% | -$94.0K |
| D | 2026-02-03 | 2026-01-30 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +204.0K | 1.02M | +25% | $0 |
| T | 2025-03-04 | 2025-03-03 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.83 | -7,144 | 809.1K | -0.9% | -$13.1K |
| DMT | 2025-02-04 | 2025-02-03 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.10 | -50.5K | 816.2K | -6% | -$106.1K |
| DT | 2025-02-04 | 2025-01-31 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +194.9K | 866.7K | +29% | $0 |
| 2024-05-09 | 2023-08-25 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.15 | -27.0K | 668.8K | -4% | -$31.0K | |
| 2024-03-01 | 2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.58 | -7,169 | 695.8K | -1% | -$11.3K | |
| T | 2024-02-29 | 2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.52 | -8,367 | 703.0K | -1% | -$12.7K |
| D | 2024-02-02 | 2024-02-01 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.68 | -24.3K | 711.4K | -3% | -$40.8K |
| D | 2024-02-02 | 2024-01-31 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +202.2K | 735.7K | +38% | $0 |
| 2023-05-18 | 2023-05-16 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $1.07 | -63.6K | 530.5K | -11% | -$68.0K | |
| M | 2023-03-03 | 2023-03-01 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.88 | -14.1K | 601.6K | -2% | -$12.4K |
| 2023-03-01 | 2023-02-27 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.81 | -7,539 | 608.2K | -1% | -$6,107 | |
| D | 2023-02-02 | 2023-01-31 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +196.2K | 615.7K | +47% | $0 |
| 2022-09-01 | 2022-08-31 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $0.36 | -1,147 | 418.0K | -0.3% | -$412.92 | |
| D | 2022-05-16 | 2022-05-12 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +200.0K | 417.7K | +92% | $0 |
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.16 | -15.1K | 217.7K | -6% | -$32.5K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +60.0K | 223.8K | +37% | $0 |
| 2021-09-02 | 2021-08-31 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.83 | -1,042 | 171.2K | -0.6% | -$2,949 |
Purchase Sale Sale after option exercise All abbreviations